A Case of Doxifluridine-Induced Ro/SSA-Positive Cutaneous Lupus Erythematosus / 대한피부과학회지
Korean Journal of Dermatology
; : 936-938, 2004.
Article
in Ko
| WPRIM
| ID: wpr-38375
Responsible library:
WPRO
ABSTRACT
Anti-Ro/SSA antibody positive drug-induced lupus erythematosus is characterized by erythematous papules at the photodistributed area after drug intake, positive anti-Ro/SSA antibody tests and histopathologic features of lupus erythematosus. A 68-year-old man was referred to our clinic with multiple erythematous violacious plaques on the face of 2 months' duration. After surgical removal of stomach cancer, he had been taking doxifluridine for 10 months. A histopathologic study revealed findings consistent with lupus erythematosus and the anti-Ro/SSA antibody was positive on the serologic test. Based on these findings, we diagnosed this case as anti-Ro/SSA antibody positive drug-induced lupus erythematosus, and report it with review of the literature.
Key words
Full text:
1
Index:
WPRIM
Main subject:
Stomach Neoplasms
Limits:
Humans
/
Male
Language:
Ko
Journal:
Korean Journal of Dermatology
Year:
2004
Type:
Article